UK Markets open in 6 hrs 27 mins

Genmab A/S (GMAB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
44.26+1.32 (+3.07%)
At close: 4:00PM EDT
44.22 -0.04 (-0.09%)
After hours: 07:52PM EDT
Sign in to post a message.
  • a
    ageninrussia
    BAL will get approved.

    The approval of the following From loncar:

    Lately the news has been ADC palooza. $SGEN & $GMAB were just approved in cervical cancer.

    https://investor.seagen.com/press-releases/news-details/2021/Seagen-and-Genmab-Announce-FDA-Accelerated-Approval-for-TIVDAK-tisotumab-vedotin-tftv-in-Previously-Treated-Recurrent-or-Metastatic-Cervical-Cancer/default.aspx
  • M
    Manos
    Why is it falling right now though? I can't see any bad press or anything (will be buying the dip ofc)
  • H
    Herman
    We will see 100 this year!
    Takeover rumours are increased
  • L
    Leon
    Down 4% extended hours, please keep staying low so I can buy more
  • P
    PAUL
    Anyone know why the recent increase sp?
  • S
    Stocks Technical
    Hoping for this GMAB bounce intraday. Nice mention alongside a few cancer stocks today so I'm happy so far https://valuemarket.exchange/45r6sh
  • B
    Bunny
    My target price is 57 to 65 dollars in the short term. In the long term, the growth could be exponential.
  • K
    Kroptie
    Even Pipeline expanding. genmab is like a mutual find of biotech with over 20 candidates over 33 different indications
  • J
    James
    It look be just a matter of time until someone takes this company out. Great pipeline/no debt and plenty of cash on hand. Just hold and wait.
  • J
    James
    Looks like things are starting are starting to heat up. Horizon report on may 5th be interesting and seeing how the Tepezza sales are going. I have a feeling in 2 years this stock price will double as there is a lot coming down the pipeline just my gut from what I have been reading
  • D
    Div
    Great pipeline and Darzalex Fast Pro off to a good start even during Covid. Can’t get a better pipeline and already in the black for a young US company- IPO wasn’t that long ago! Long and strong/ forget that sell side today!! Want to get the shares cheaper as the analysts wake up to a great company!!
  • B
    Bunny
    Free Cash Flow increasing from 1.2 billions to over 6 billions DKK. That is almost 600% jump with further growth and recurring revenue ! This is a super growth stock. Stock price will jump.
  • K
    Kroptie
    When JNJ took out Actelion for $30 billion it had no earnings and paid $280 a share. Genmab has $250 million USD net income already and is valued at only 6 billion.Putting same price on Genmab would be $500
  • I
    Imme
    What is this ...GMAB gets FDA approval on an MS drug and no market reaction??? I just bought some... hoping for markets react positively....
  • M
    ML
    Copenhagen, Denmark; January 15, 2021 – Genmab A/S (Nasdaq: GMAB) announced today that the U.S. Food and Drug Administration (U.S. FDA) has approved the use of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj), a subcutaneous formulation of daratumumab, in combination with bortezomib, cyclophosphamide, and dexamethasone (VCd) for the treatment of adult patients with newly diagnosed light-chain (AL) amyloidosis.
  • K
    Kroptie
    I listened to conference. Newest Darzulex indication just approved by FDA yesterday could double royalty income from JNJ in coming year
  • K
    Kim
    $SRPT conversation
    Highlights from RBC 2020 #biotech outlook

    Top Ideas: $GILD $GMAB $SRPT $EXEL $ACAD $OVID $MOLN $ATNX $APRE $CLIN $APTO
  • L
    Larry
    $AGEN conversation
    Stolen from the twitterverse:

    Genmab $GMAB Announces Very Favorable Topline Results from Phase 2 Clinical Trial of Tisotumab Vedotin in Recurrent or Metastatic Cervical Cancer

    $GMAB was targeting 20-ish % and min DOR 6mo so targets met with 24% and 8.3mo.
  • W
    William
    dont know why this didnt move on the abbvie news.
  • K
    Kroptie
    Split shares because management feels undervalued